A novel potent class I HDAC inhibitor reverses the STAT4/p66Shc apoptotic defect in B cells from chronic lymphocytic leukemia patients
Article in Biomedicine & Pharmacotherapy (April 2024)
The most recent citing publications are shown below. View all 6 publications that cite this research output on Dimensions.
Article in Biomedicine & Pharmacotherapy (April 2024)
Article in Cell Death & Disease (February 2024)
Article in Hematological Oncology (February 2024)